	US 11,678,923 B2
	Anisotropic biocomposite material, medical implants comprising same and methods of treatment thereof
Orahn Preiss-Bloom, Zichron Yakov (IL); and Taly Pnina Lindner, Savyon (IL)
Assigned to OSSIO, LTD., Binyamina (IL)
Filed by Ossio Ltd., Binyamina (IL)
Filed on Nov. 18, 2020, as Appl. No. 16/951,109.
Application 16/951,109 is a continuation of application No. 15/509,301, granted, now 10,869,708, previously published as PCT/IL2015/050903, filed on Sep. 7, 2015.
Claims priority of provisional application 62/047,023, filed on Sep. 7, 2014.
Prior Publication US 2021/0137576 A1, May 13, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61L 27/50 (2006.01); A61B 17/88 (2006.01); A61L 27/36 (2006.01); A61L 27/44 (2006.01); A61B 17/16 (2006.01); A61F 2/30 (2006.01); A61B 17/86 (2006.01); A61L 31/06 (2006.01); A61L 31/16 (2006.01); A61B 17/80 (2006.01); A61L 31/12 (2006.01); A61L 31/14 (2006.01); A61B 17/04 (2006.01); A61B 17/064 (2006.01); A61B 17/00 (2006.01); A61B 17/12 (2006.01); A61B 17/122 (2006.01)

CPC A61B 17/8875 (2013.01) [A61B 17/16 (2013.01); A61B 17/1615 (2013.01); A61B 17/1617 (2013.01); A61B 17/80 (2013.01); A61B 17/863 (2013.01); A61B 17/864 (2013.01); A61B 17/866 (2013.01); A61B 17/8625 (2013.01); A61B 17/8635 (2013.01); A61F 2/30965 (2013.01); A61L 27/365 (2013.01); A61L 27/446 (2013.01); A61L 27/50 (2013.01); A61L 31/06 (2013.01); A61L 31/128 (2013.01); A61L 31/148 (2013.01); A61L 31/16 (2013.01); A61B 17/0401 (2013.01); A61B 17/064 (2013.01); A61B 17/122 (2013.01); A61B 17/12009 (2013.01); A61B 2017/00004 (2013.01); A61B 2017/00964 (2013.01); A61L 2430/02 (2013.01)]

15 Claims

1. An orthopedic implant comprising a biodegradable composite, the biodegradable composite comprising a reinforcement filler, wherein said reinforcement filler comprises a plurality of reinforcing fibers; wherein said biodegradable composite further comprises a biodegradable polymer; wherein an average density of the biodegradable composite is in a range of 1.3-3.0 g/cm³; wherein an inherent viscosity (IV) of the biodegradable polymer alone is in the range of 1.0 to 3.0 dl/g; and wherein a percentage of reinforcing fibers is in the range of 40% to 50% weight per weight; wherein a plurality of said reinforcement fibers are arranged in parallel to a longitudinal axis of the implant.